Literature DB >> 11968539

[Long-term outcomes after using porous hydroxyapatite ceramics (Endobon) for surgical management of fractures of the head of the tibia].

D Briem1, W Linhart, W Lehmann, N M Meenen, J M Rueger.   

Abstract

Endobon is a porous hydroxyapatite ceramic which has been used as a bone replacement substitute since 1989. Currently there are no data available reflecting long-term effects of Endobon in human bone grafting. In order to assess such effects 35 patients with fractures of the proximal tibia were studied retrospectively over a period up to 91 months. The metaphyseal defects were filled by Endobon and fractures were stabilized by internal plate fixation subsequently. A secondary loss of reduction due to mechanical failure of the bone replacement material did not occur even after removal of metal implants. No histological signs of resorption or degradation could be found 18 months after application. Our data show that Endobon provides good mechanical properties during a long term follow-up and can be recommended as a suitable therapeutic option versus cancellous bone graft.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11968539     DOI: 10.1007/s001130100303

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  10 in total

1.  In vivo behaviour of low-temperature calcium-deficient hydroxyapatite: comparison with deproteinised bovine bone.

Authors:  Pavel Sponer; Marie Strnadová; Karel Urban
Journal:  Int Orthop       Date:  2010-08-19       Impact factor: 3.075

2.  [Conductive bone substitute material with variable antibiotic delivery].

Authors:  C Englert; P Angele; J Fierlbeck; S Dendorfer; T Schubert; R Müller; S Lienhard; J Zellner; M Nerlich; C Neumann
Journal:  Unfallchirurg       Date:  2007-05       Impact factor: 1.000

Review 3.  [Bone substitutes].

Authors:  M Schieker; C Heiss; W Mutschler
Journal:  Unfallchirurg       Date:  2008-08       Impact factor: 1.000

4.  Low temperature fabrication of spherical brushite granules by cement paste emulsion.

Authors:  Claus Moseke; Christoph Bayer; Elke Vorndran; Jake E Barralet; Jürgen Groll; Uwe Gbureck
Journal:  J Mater Sci Mater Med       Date:  2012-08-19       Impact factor: 3.896

5.  Evaluation of a novel nanocrystalline hydroxyapatite paste Ostim in comparison to Alpha-BSM - more bone ingrowth inside the implanted material with Ostim compared to Alpha BSM.

Authors:  Franz-Xaver Huber; Nicholas McArthur; Lydia Heimann; Elvira Dingeldein; Héloïse Cavey; Xavier Palazzi; Gaëlle Clermont; Jean-Pierre Boutrand
Journal:  BMC Musculoskelet Disord       Date:  2009-12-22       Impact factor: 2.362

6.  [Solid body augmentation for comminuted calcaneal fractures : development and biomechanical testing of a hybrid osteosynthesis technique].

Authors:  S Brodt; A Gisep; K Schwieger; N Suhm; A Appelt
Journal:  Unfallchirurg       Date:  2007-12       Impact factor: 1.000

7.  Evaluation of a novel nanocrystalline hydroxyapatite paste and a solid hydroxyapatite ceramic for the treatment of critical size bone defects (CSD) in rabbits.

Authors:  Franz-Xaver Huber; Irina Berger; Nicholas McArthur; Colette Huber; Hans-Peter Kock; Jürgen Hillmeier; Peter Jürgen Meeder
Journal:  J Mater Sci Mater Med       Date:  2007-06-14       Impact factor: 3.896

8.  [Mechanical failure of porous hydroxyapatite ceramics 7.5 years after implantation in the proximal tibial].

Authors:  W Linhart; D Briem; M Amling; J M Rueger; J Windolf
Journal:  Unfallchirurg       Date:  2004-02       Impact factor: 1.000

9.  A New Injectable Brushite Cement: First Results in Distal Radius and Proximal Tibia Fractures.

Authors:  Christian Ryf; Sabine Goldhahn; Marek Radziejowski; Michael Blauth; Beate Hanson
Journal:  Eur J Trauma Emerg Surg       Date:  2009-05-12       Impact factor: 3.693

10.  SEM-EDX Study of the Degradation Process of Two Xenograft Materials Used in Sinus Lift Procedures.

Authors:  María Piedad Ramírez Fernández; Sergio A Gehrke; Carlos Pérez Albacete Martinez; Jose L Calvo Guirado; Piedad N de Aza
Journal:  Materials (Basel)       Date:  2017-05-17       Impact factor: 3.623

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.